Ignite Creation Date:
2024-05-06 @ 2:38 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04370054
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-04
First Post:
2020-04-21
Brief Title:
Study to Evaluate the Efficacy and Safety of PF-07055480 Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-25
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-21
First Submit QC Date:
April 29 2020
Study First Post Date:
2020-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-23
Last Update Post Date:
2024-03-04
Last Update Post Date Type:
ACTUAL